Abstract
Molecular imaging allows noninvasive assessment of drug distribution across pharmacological barriers. Thus, it plays an increasingly important role in efforts to understand the interactions of molecules with membrane transporters during drug development and in clinical pharmacology. We describe established and emerging imaging modalities utilized for studying transporter expression and function. We further present examples of how molecular imaging could provide insights into the contribution of transporters to drug disposition and effects.
| Original language | American English |
|---|---|
| Pages (from-to) | 479-488 |
| Number of pages | 10 |
| Journal | Clinical Pharmacology and Therapeutics |
| DOIs | |
| State | Published - 1 Nov 2016 |
Bibliographical note
Funding Information:The authors wish to thank Ms. Judy Dotan who assisted in the proofreading of the manuscript. This work was supported by grants from the Israel Science Foundation (ISF; #506/13), The National Institute for Psychobiology in Israel, and the Israeli Cancer Research Foundation (ICRF).
Publisher Copyright:
© 2016 American Society for Clinical Pharmacology and Therapeutics